Coronary Heart Disease Clinical Trials in Shenyang, Liaoning
4 recruitingShenyang, Liaoning, China
Showing 1–4 of 4 trials
Recruiting
Not Applicable
Closed-Loop Neurofeedback Targeting the Left Dorsolateral Prefrontal Cortex for Cardiac Autonomic Modulation in Coronary Artery Disease With Anxiety
Coronary Heart Disease (CHD)Anxiety Disorders
Shenyang Medical College56 enrolled1 locationNCT07244484
Recruiting
Not Applicable
Closed-Loop Neurofeedback Targeting the Right Dorsolateral Prefrontal Cortex for Cardiac Autonomic Modulation in Coronary Artery Disease With Anxiety
Coronary Heart Disease (CHD)Anxiety Disorders
Shenyang Medical College56 enrolled1 locationNCT07238920
Recruiting
Phase 4
Efficacy and Safety Trials of Yangxinshi Tablets in the Treatment of Patients With Coronary Heart Disease Complicated by Cardiac Dysfunction
Coronary Heart Disease
SPH Qingdao Growful Pharmacetical Co.,Ltd2,708 enrolled96 locationsNCT07110415
Recruiting
Clinical Outcomes of Patients With Coronary Artery Disease
Coronary Heart Disease (CHD)
Shenyang Northern Hospital10,000 enrolled1 locationNCT06216847